Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus-Reference-Cited by-同舟云学术

Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus

Published:2018-07 Issue:6 Volume:29 Page:565-571
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Terakawa Tomoaki,Hussein Ahmed A.,Bando Yukari,Guru Khurshid A.,Furukawa Junya,Shigemura Katsumi,Harada Kenichi,Hinata Nobuyuki,Nakano Yuzou,Fujisawa Masato

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference38 articles.

1. Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins;Marshall;J Urol,1988

2. Surgical management and prognosis of renal cell carcinoma invading the vena cava;Hatcher;J Urol,1991

3. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus;Lambert;Urology,2007

4. Prognostic factors for renal cell carcinoma with tumor thrombus extension;Klatte;J Urol,2007

5. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome;Al Otaibi;BJU Int,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature Review;Cancers;2023-11-13

2. Cine magnetic resonance imaging predicts thrombus adhesion in metastatic renal cell carcinoma with an inferior vena cava tumor thrombus: A case of pathological complete response with pembrolizumab plus lenvatinib;IJU Case Reports;2023-11-08

3. The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus;Clinical Genitourinary Cancer;2023-10

4. Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary;BJU International;2023-01-25

5. Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus;Journal of Immunotherapy and Precision Oncology;2022-11-07